Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
English
Français
Canada
Sandoz Site Directory
Our Work
What We Do
Quality Generics
Biopharmaceuticals
Specialty Products
About Us
Who We Are
Corporate Responsibility
Doing Business Responsibly
Contact Us
Grants, Donations and Sponsorships
Products
Consumers
Patients
Healthcare Professionals
Patient Support Programs
News
Media Releases
Media Resource Center
Stay Up-To-Date
Careers
Available Positions
Join the Sandoz Manufacturing team in Boucherville
Our Benefits
Employee Testimonials
Our Values and Vision
Diversity & Inclusion
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Media Releases
Filter By
2018
May
Media Release
/
May 25, 2018
Important Announcement: Avara intends to acquire our plant and development center in Boucherville.
Read More
April
Media Release
/
Apr 19, 2018
Four Canadian provinces add Erelzi™ (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
Read More
March
Media Release
/
Mar 07, 2018
Sandoz Canada launches two new generic therapies for hypertension
Read More
February
Media Release
/
Feb 06, 2018
Sandoz Canada amongst Top Employers in Montreal
Read More
Media Release
/
Feb 05, 2018
Quebec adds Erelzi™ (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
Read More
January
Media Release
/
Jan 09, 2018
Ontario has added ErelziTM (etanercept) to public drug plan for the treatment of multiple inflammatory diseases
Read More
2017
November
Media Release
/
Nov 16, 2017
British Columbia and Prince Edward Island become the first provinces to add ErelziTM (etanercept) to public drug plans for the treatment of multiple inflammatory diseases
Read More
October
Media Release
/
Oct 27, 2017
Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review
Read More
August
Media Release
/
Aug 20, 2017
Sandoz ErelziTM (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases
Read More
Media Release
/
Aug 20, 2017
ErelziTM (etanercept), by Sandoz, is now available for patients in Canada for the treatment of multiple inflammatory diseases
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
Page
1
of 5
Current page
2
of 5
Page
3
of 5
Page
4
of 5
Page
5
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
You are here
Home
›
